Delivery Order SPE2DB22D9239-SPE2DB24FDH68
Award Date 3/29/24
Potential Completion Date 4/19/24
Potential Value $16K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $34,251.00 contract is for the supply of PRIVIGEN 10% VIAL 200ML, a specialized pharmaceutical product. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders for a wide range of pharmaceutical items...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $19,202.40 and is for the delivery of PRIVIGEN 10% VIAL 200ML, a pharmaceutical product. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This single-award IDC...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $4,940.10 award is for the delivery of PRIVIGEN 10% VIAL 50ML, a specialized pharmaceutical product. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA, which enables the agency to issue firm fixed-price orders for a comprehensive range...
- This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for a $79,041.60 firm fixed-price delivery order from the Defense Logistics Agency (DLA) to provide 400 ml vials of the pharmaceutical product PRIVIGEN 10%. The contract has an ultimate completion date of November 7, 2024. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which provides a range of branded and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $32,934.00 contract is for the supply of PRIVIGEN 10% vial, a pharmaceutical product, with a period of performance through August 13, 2024. This award is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued up to $499,999,999, which allows the DLA...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $34,251.00 contract is for the delivery of PRIVIGEN 10% VIAL 200ML, a specialized pharmaceutical product, to support the medical supply needs of military health facilities. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, enabling the...
- The Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product PRIVIGEN 10% VIAL 50ML. This delivery order, valued at $3,884.25, is part of a larger indefinite delivery contract held by DMS Pharmaceutical Group Inc. to supply a variety of medical supplies and pharmaceuticals to DLA Troop Support Medical facilities worldwide. The contract has a completion date of January 18,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The $51,376.50 contract is for the provision of PRIVIGEN 10% vial, a 200 ml pharmaceutical product. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to support the medical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $58,226.70, is for the delivery of PRIVIGEN 10% VIAL 200ML, a specialized pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program. This IDC enables...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $32,934 contract is for the supply of PRIVIGEN 10% VIAL 200ML, a pharmaceutical product, with a period of performance through October 7, 2024. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB24FDH68Delivery Order
This contract award, valued at $16,002.00, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of 100ML vials of the pharmaceutical product PRIVIGEN 10%. The contract is a delivery order under the DLA's broader Indefinite Delivery/Indefinite Quantity (IDIQ) contract SPE2DB, which has a ceiling value of up to $4,999,999 and enables the agency to place orders for a wide range of pharmaceutical items to support military medical facilities worldwide. This specific delivery order has a firm fixed price and a completion date of April 19, 2024. The contract does not have a set-aside designation.
Generated 6/28/24, 9:12 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.0k | 3/29/24 |